Rite Aid (RAD) Tops Q3 EPS by 1c; Lowers Outlook

Rite Aid (NYSE: RAD) reported Q3 EPS of ($0.14), $0.01 better than the analyst estimate of ($0.15). Revenue for the quarter came in at $6.1 billion versus the consensus estimate of $5.94 billion.

GUIDANCE:

Rite Aid sees FY2023 EPS of ($2.18)-($1.78), versus the consensus of ($1.78). Fiscal 2023 Adjusted EBITDA Outlook Lowered to $410 million to $440 million.

For earnings history and earnings-related data on Rite Aid (RAD) click here.

You May Also Be Interested In

• DocGo (DCGO) Misses Q2 EPS by 6c; Offers Guidance
• INVO Fertility (IVF) Tops Q2 EPS by 105c
• Radiopharm sets FDA meeting for RAD101 brain metastases trial design